Reach Banner
Last name



This is a "connection" page, showing publications co-authored by Oussama Abla and Adam Shlien.

Connection Strength
  1. Tandon S, Bartram J, Kyriakopoulou L, Kanwar N, Lo W, Davidson S, Punnett A, Shlien A, Hitzler J, Malkin D, Villani A, Abla O. Failure of Romidepsin to Treat Relapsed/Refractory Peripheral T-Cell Lymphoma in Children: A Single-center Experience. J Pediatr Hematol Oncol. 2021 07 01; 43(5):e745-e748.
    View in: PubMed
    Score: 0.245
  2. Tandon S, Shago M, Davidson S, Kanwar N, Fuligni F, Shlien A, Whitlock J, Villani A, Abla O. First report of t(5;11) KMT2A-MAML1 fusion in de novo infant acute lymphoblastic leukemia. Cancer Genet. 2020 10; 248-249:31-33.
    View in: PubMed
    Score: 0.232
  3. Langenberg-Ververgaert K, Renzi S, Fuligni F, Davidson S, Abdelhaleem M, Lo W, Malkin D, Shlien A, Shago M, Villani A, Abla O. TERT promotor variant associated with poor clinical outcome in a patient with novel RBM15-MKL1 fusion-positive pediatric acute megakaryoblastic leukemia. Pediatr Blood Cancer. 2021 01; 68(1):e28542.
    View in: PubMed
    Score: 0.230
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.